2010
DOI: 10.1101/gad.1960210
|View full text |Cite|
|
Sign up to set email alerts
|

The epigenome and the mitochondrion: bioenergetics and the environment

Abstract: In the July 15, 2010, issue of Genes & Development, Yoon and colleagues (pp. 1507–1518) report that, in a siRNA knockdown survey of 6363 genes in mouse C2C12 cells, they discovered 150 genes that regulated mitochondrial biogenesis and bioenergetics. Many of these genes have been studied previously for their importance in regulating transcription, protein and nucleic acid modification, and signal transduction. Some notable examples include Brac1, Brac2, Pax4, Sin3A, Fyn, Fes, Map2k7, Map3k2, calmodulin 3, C… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
32
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(32 citation statements)
references
References 13 publications
0
32
0
Order By: Relevance
“…To review mitochondrial diseases may be a very difficult task because the definition might include different kinds of metabolic disorders or degenerative syndromes [24]. Moreover, some important aspects have been extensively reviewed and the reader might refer to very good recent articles by DiMauro and Garone [25] for historical aspects, by Wallace et al [26,27] for bioenergetics, by Spinazzola and Zeviani [28] for nucleomitochondrial intergenomic cross-talk. The previous review by Schwimmer et al [29] was given an important outline of yeast models of mitochondrial diseases.…”
Section: The Role Of Sdh In Human Diseasementioning
confidence: 99%
“…To review mitochondrial diseases may be a very difficult task because the definition might include different kinds of metabolic disorders or degenerative syndromes [24]. Moreover, some important aspects have been extensively reviewed and the reader might refer to very good recent articles by DiMauro and Garone [25] for historical aspects, by Wallace et al [26,27] for bioenergetics, by Spinazzola and Zeviani [28] for nucleomitochondrial intergenomic cross-talk. The previous review by Schwimmer et al [29] was given an important outline of yeast models of mitochondrial diseases.…”
Section: The Role Of Sdh In Human Diseasementioning
confidence: 99%
“…Furthermore, many activities controlling chromatin dynamics require metabolites that shuttle between different cellular functions and pathways. One critical facet of histone and DNA modifying enzymes is that their activity also depends on intracellular levels of essential metabolites (acetyl-coA, Fe, ketoglutarate, NAD+, S-adenosylmethionine, see Figure 1) of which the concentrations are tighly linked to global cellular metabolism and energy levels (Bellet & Sassone-Corsi, 2010;Chang et al, 2010;Ladurner, 2009;Luo & Kuo, 2009;Wallace, 2010a;2010b). Gene regulation is thus linked to the metabolic status of cells.…”
Section: Introductionmentioning
confidence: 99%
“…At the single-cell level, protocadherin-alpha mRNAs are regulated monoallelically, supporting the idea that diversified protocadherin molecules contribute to neural circuit development and provide individual cells with their specific identity (Hilschmann et al, 2001). The neocortical genomic response to stress is relayed via hormones and reactive oxygen/nitrogen species signaling, thereby implicating the mitochondrial genome and bioenergetic metabolism (Wallace, 2010), which is suggested to represent an extension of dynamic genomic changes in parallel to the immune recombination and neural rearrangement (protocadherin) histories and fragile site events ) of a particular individual.…”
Section: Protocadherin Genetic Rearrangement In the Brainmentioning
confidence: 99%
“…Furthermore, bioenergetic metabolism as related to mitochondrial genetics (including both mitochondrial genes and nuclear genes involved with bioenergetic crosstalk) (Wallace, 2010) as well as epigenetic modification of DNA regulatory structures are considered to be increasingly important in neuroplasticity. Most of the gene identification studies have assayed for only one type of epigenetic marker.…”
Section: Analytical Challenges In Building Complex Disease Investigatmentioning
confidence: 99%